nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.0427	0.0532	CcSEcCtD
Triamcinolone—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.0427	0.0532	CcSEcCtD
Triamcinolone—Benign intracranial hypertension—Liotrix—hypothyroidism	0.0314	0.0391	CcSEcCtD
Triamcinolone—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.0227	0.0282	CcSEcCtD
Triamcinolone—Menstruation irregular—Levothyroxine—hypothyroidism	0.0227	0.0282	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0205	0.0255	CcSEcCtD
Triamcinolone—NR3C1—urine—hypothyroidism	0.0179	0.0937	CbGeAlD
Triamcinolone—Hypernatraemia—Liotrix—hypothyroidism	0.0176	0.0219	CcSEcCtD
Triamcinolone—Menstruation irregular—Liotrix—hypothyroidism	0.0167	0.0208	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0141	0.0176	CcSEcCtD
Triamcinolone—Myocardial infarction—Liothyronine—hypothyroidism	0.014	0.0175	CcSEcCtD
Triamcinolone—CYP3A4—urine—hypothyroidism	0.0135	0.0709	CbGeAlD
Triamcinolone—NR3C1—nerve—hypothyroidism	0.0123	0.0647	CbGeAlD
Triamcinolone—Wheezing—Dextrothyroxine—hypothyroidism	0.0122	0.0152	CcSEcCtD
Triamcinolone—Wheezing—Levothyroxine—hypothyroidism	0.0122	0.0152	CcSEcCtD
Triamcinolone—Abscess—Liotrix—hypothyroidism	0.0117	0.0145	CcSEcCtD
Triamcinolone—Arrhythmia—Liothyronine—hypothyroidism	0.0115	0.0143	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.01	0.0125	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.01	0.0125	CcSEcCtD
Triamcinolone—Ulcer—Liotrix—hypothyroidism	0.00976	0.0122	CcSEcCtD
Triamcinolone—Increased appetite—Dextrothyroxine—hypothyroidism	0.0097	0.0121	CcSEcCtD
Triamcinolone—Increased appetite—Levothyroxine—hypothyroidism	0.0097	0.0121	CcSEcCtD
Triamcinolone—Hypertension—Liothyronine—hypothyroidism	0.00965	0.012	CcSEcCtD
Triamcinolone—Affect lability—Dextrothyroxine—hypothyroidism	0.00897	0.0112	CcSEcCtD
Triamcinolone—Affect lability—Levothyroxine—hypothyroidism	0.00897	0.0112	CcSEcCtD
Triamcinolone—Wheezing—Liotrix—hypothyroidism	0.00897	0.0112	CcSEcCtD
Triamcinolone—Tachycardia—Liothyronine—hypothyroidism	0.0089	0.0111	CcSEcCtD
Triamcinolone—Fluid retention—Liotrix—hypothyroidism	0.00877	0.0109	CcSEcCtD
Triamcinolone—SERPINA6—pituitary gland—hypothyroidism	0.00874	0.0458	CbGeAlD
Triamcinolone—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00867	0.0108	CcSEcCtD
Triamcinolone—Cardiac arrest—Levothyroxine—hypothyroidism	0.00867	0.0108	CcSEcCtD
Triamcinolone—Mood swings—Dextrothyroxine—hypothyroidism	0.00863	0.0108	CcSEcCtD
Triamcinolone—Mood swings—Levothyroxine—hypothyroidism	0.00863	0.0108	CcSEcCtD
Triamcinolone—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00804	0.01	CcSEcCtD
Triamcinolone—Muscular weakness—Levothyroxine—hypothyroidism	0.00804	0.01	CcSEcCtD
Triamcinolone—SERPINA6—adrenal gland—hypothyroidism	0.0078	0.0409	CbGeAlD
Triamcinolone—SERPINA6—blood—hypothyroidism	0.0078	0.0409	CbGeAlD
Triamcinolone—Sweating increased—Levothyroxine—hypothyroidism	0.00767	0.00956	CcSEcCtD
Triamcinolone—Sweating increased—Dextrothyroxine—hypothyroidism	0.00767	0.00956	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Liotrix—hypothyroidism	0.00739	0.00921	CcSEcCtD
Triamcinolone—Body temperature increased—Liothyronine—hypothyroidism	0.00721	0.00898	CcSEcCtD
Triamcinolone—Increased appetite—Liotrix—hypothyroidism	0.00713	0.00889	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00692	0.00862	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00692	0.00862	CcSEcCtD
Triamcinolone—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00688	0.00857	CcSEcCtD
Triamcinolone—Myocardial infarction—Levothyroxine—hypothyroidism	0.00688	0.00857	CcSEcCtD
Triamcinolone—Affect lability—Liotrix—hypothyroidism	0.0066	0.00822	CcSEcCtD
Triamcinolone—Cardiac arrest—Liotrix—hypothyroidism	0.00637	0.00794	CcSEcCtD
Triamcinolone—Mood swings—Liotrix—hypothyroidism	0.00635	0.00791	CcSEcCtD
Triamcinolone—SERPINA6—liver—hypothyroidism	0.0061	0.032	CbGeAlD
Triamcinolone—SERPINA6—cerebellum—hypothyroidism	0.00596	0.0313	CbGeAlD
Triamcinolone—Muscular weakness—Liotrix—hypothyroidism	0.00591	0.00736	CcSEcCtD
Triamcinolone—Abdominal distension—Liotrix—hypothyroidism	0.00583	0.00726	CcSEcCtD
Triamcinolone—Sweating increased—Liotrix—hypothyroidism	0.00564	0.00703	CcSEcCtD
Triamcinolone—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00563	0.00701	CcSEcCtD
Triamcinolone—Arrhythmia—Levothyroxine—hypothyroidism	0.00563	0.00701	CcSEcCtD
Triamcinolone—Bronchitis—Liotrix—hypothyroidism	0.00557	0.00694	CcSEcCtD
Triamcinolone—BCHE—heart—hypothyroidism	0.00514	0.027	CbGeAlD
Triamcinolone—Acute coronary syndrome—Liotrix—hypothyroidism	0.00509	0.00634	CcSEcCtD
Triamcinolone—Myocardial infarction—Liotrix—hypothyroidism	0.00506	0.00631	CcSEcCtD
Triamcinolone—Angioedema—Dextrothyroxine—hypothyroidism	0.00501	0.00625	CcSEcCtD
Triamcinolone—Angioedema—Levothyroxine—hypothyroidism	0.00501	0.00625	CcSEcCtD
Triamcinolone—BCHE—cardiovascular system—hypothyroidism	0.00485	0.0255	CbGeAlD
Triamcinolone—Convulsion—Dextrothyroxine—hypothyroidism	0.00475	0.00592	CcSEcCtD
Triamcinolone—Convulsion—Levothyroxine—hypothyroidism	0.00475	0.00592	CcSEcCtD
Triamcinolone—NR3C1—adrenal cortex—hypothyroidism	0.00473	0.0248	CbGeAlD
Triamcinolone—NR3C1—heart—hypothyroidism	0.00458	0.024	CbGeAlD
Triamcinolone—Shock—Dextrothyroxine—hypothyroidism	0.00441	0.00549	CcSEcCtD
Triamcinolone—Shock—Levothyroxine—hypothyroidism	0.00441	0.00549	CcSEcCtD
Triamcinolone—Tachycardia—Levothyroxine—hypothyroidism	0.00437	0.00544	CcSEcCtD
Triamcinolone—Tachycardia—Dextrothyroxine—hypothyroidism	0.00437	0.00544	CcSEcCtD
Triamcinolone—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00433	0.00539	CcSEcCtD
Triamcinolone—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00433	0.00539	CcSEcCtD
Triamcinolone—NR3C1—cardiovascular system—hypothyroidism	0.00432	0.0227	CbGeAlD
Triamcinolone—BCHE—pituitary gland—hypothyroidism	0.0043	0.0225	CbGeAlD
Triamcinolone—Arrhythmia—Liotrix—hypothyroidism	0.00414	0.00516	CcSEcCtD
Triamcinolone—PTGS2—adrenal cortex—hypothyroidism	0.0041	0.0215	CbGeAlD
Triamcinolone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00408	0.00508	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00408	0.00508	CcSEcCtD
Triamcinolone—Insomnia—Dextrothyroxine—hypothyroidism	0.00405	0.00505	CcSEcCtD
Triamcinolone—Insomnia—Levothyroxine—hypothyroidism	0.00405	0.00505	CcSEcCtD
Triamcinolone—Dyspnoea—Levothyroxine—hypothyroidism	0.00399	0.00497	CcSEcCtD
Triamcinolone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00399	0.00497	CcSEcCtD
Triamcinolone—PTGS2—heart—hypothyroidism	0.00396	0.0208	CbGeAlD
Triamcinolone—Dysgeusia—Liotrix—hypothyroidism	0.00395	0.00492	CcSEcCtD
Triamcinolone—NR3C1—gonad—hypothyroidism	0.00392	0.0206	CbGeAlD
Triamcinolone—Fatigue—Dextrothyroxine—hypothyroidism	0.00386	0.00481	CcSEcCtD
Triamcinolone—Fatigue—Levothyroxine—hypothyroidism	0.00386	0.00481	CcSEcCtD
Triamcinolone—BCHE—adrenal gland—hypothyroidism	0.00384	0.0201	CbGeAlD
Triamcinolone—BCHE—blood—hypothyroidism	0.00384	0.0201	CbGeAlD
Triamcinolone—NR3C1—pituitary gland—hypothyroidism	0.00383	0.0201	CbGeAlD
Triamcinolone—PTGS2—cardiovascular system—hypothyroidism	0.00374	0.0196	CbGeAlD
Triamcinolone—BCHE—thyroid gland—hypothyroidism	0.0037	0.0194	CbGeAlD
Triamcinolone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00369	0.0046	CcSEcCtD
Triamcinolone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00369	0.0046	CcSEcCtD
Triamcinolone—Angioedema—Liotrix—hypothyroidism	0.00369	0.00459	CcSEcCtD
Triamcinolone—Syncope—Liotrix—hypothyroidism	0.00362	0.00451	CcSEcCtD
Triamcinolone—Urticaria—Levothyroxine—hypothyroidism	0.00356	0.00443	CcSEcCtD
Triamcinolone—Urticaria—Dextrothyroxine—hypothyroidism	0.00356	0.00443	CcSEcCtD
Triamcinolone—Loss of consciousness—Liotrix—hypothyroidism	0.00355	0.00442	CcSEcCtD
Triamcinolone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00354	0.00441	CcSEcCtD
Triamcinolone—Body temperature increased—Levothyroxine—hypothyroidism	0.00354	0.00441	CcSEcCtD
Triamcinolone—Convulsion—Liotrix—hypothyroidism	0.0035	0.00436	CcSEcCtD
Triamcinolone—Hypertension—Liotrix—hypothyroidism	0.00349	0.00434	CcSEcCtD
Triamcinolone—NR3C1—adrenal gland—hypothyroidism	0.00342	0.0179	CbGeAlD
Triamcinolone—NR3C1—blood—hypothyroidism	0.00342	0.0179	CbGeAlD
Triamcinolone—Fluoxymesterone—SHBG—hypothyroidism	0.00335	0.622	CrCbGaD
Triamcinolone—PTGS2—pituitary gland—hypothyroidism	0.00331	0.0174	CbGeAlD
Triamcinolone—NR3C1—thyroid gland—hypothyroidism	0.0033	0.0173	CbGeAlD
Triamcinolone—Anaphylactic shock—Liotrix—hypothyroidism	0.00329	0.0041	CcSEcCtD
Triamcinolone—Oedema—Liotrix—hypothyroidism	0.00329	0.0041	CcSEcCtD
Triamcinolone—Infection—Liotrix—hypothyroidism	0.00327	0.00408	CcSEcCtD
Triamcinolone—Shock—Liotrix—hypothyroidism	0.00324	0.00404	CcSEcCtD
Triamcinolone—Tachycardia—Liotrix—hypothyroidism	0.00322	0.00401	CcSEcCtD
Triamcinolone—Asthenia—Dextrothyroxine—hypothyroidism	0.00321	0.004	CcSEcCtD
Triamcinolone—Asthenia—Levothyroxine—hypothyroidism	0.00321	0.004	CcSEcCtD
Triamcinolone—NR3C1—female gonad—hypothyroidism	0.00319	0.0167	CbGeAlD
Triamcinolone—Hyperhidrosis—Liotrix—hypothyroidism	0.00318	0.00397	CcSEcCtD
Triamcinolone—BCHE—testis—hypothyroidism	0.00317	0.0166	CbGeAlD
Triamcinolone—Pruritus—Levothyroxine—hypothyroidism	0.00317	0.00395	CcSEcCtD
Triamcinolone—Pruritus—Dextrothyroxine—hypothyroidism	0.00317	0.00395	CcSEcCtD
Triamcinolone—BCHE—liver—hypothyroidism	0.003	0.0157	CbGeAlD
Triamcinolone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.003	0.00374	CcSEcCtD
Triamcinolone—Insomnia—Liotrix—hypothyroidism	0.00298	0.00371	CcSEcCtD
Triamcinolone—Paraesthesia—Liotrix—hypothyroidism	0.00296	0.00368	CcSEcCtD
Triamcinolone—PTGS2—adrenal gland—hypothyroidism	0.00296	0.0155	CbGeAlD
Triamcinolone—PTGS2—blood—hypothyroidism	0.00296	0.0155	CbGeAlD
Triamcinolone—Dyspnoea—Liotrix—hypothyroidism	0.00294	0.00366	CcSEcCtD
Triamcinolone—BCHE—cerebellum—hypothyroidism	0.00293	0.0154	CbGeAlD
Triamcinolone—Vomiting—Levothyroxine—hypothyroidism	0.00285	0.00355	CcSEcCtD
Triamcinolone—Vomiting—Dextrothyroxine—hypothyroidism	0.00285	0.00355	CcSEcCtD
Triamcinolone—Fatigue—Liotrix—hypothyroidism	0.00284	0.00354	CcSEcCtD
Triamcinolone—NR3C1—testis—hypothyroidism	0.00283	0.0148	CbGeAlD
Triamcinolone—Rash—Dextrothyroxine—hypothyroidism	0.00282	0.00352	CcSEcCtD
Triamcinolone—Rash—Levothyroxine—hypothyroidism	0.00282	0.00352	CcSEcCtD
Triamcinolone—Dermatitis—Levothyroxine—hypothyroidism	0.00282	0.00351	CcSEcCtD
Triamcinolone—Dermatitis—Dextrothyroxine—hypothyroidism	0.00282	0.00351	CcSEcCtD
Triamcinolone—Headache—Levothyroxine—hypothyroidism	0.00281	0.00349	CcSEcCtD
Triamcinolone—Headache—Dextrothyroxine—hypothyroidism	0.00281	0.00349	CcSEcCtD
Triamcinolone—PTGS2—female gonad—hypothyroidism	0.00276	0.0145	CbGeAlD
Triamcinolone—Feeling abnormal—Liotrix—hypothyroidism	0.00271	0.00338	CcSEcCtD
Triamcinolone—NR3C1—liver—hypothyroidism	0.00267	0.014	CbGeAlD
Triamcinolone—Nausea—Dextrothyroxine—hypothyroidism	0.00266	0.00331	CcSEcCtD
Triamcinolone—Nausea—Levothyroxine—hypothyroidism	0.00266	0.00331	CcSEcCtD
Triamcinolone—Urticaria—Liotrix—hypothyroidism	0.00262	0.00326	CcSEcCtD
Triamcinolone—NR3C1—cerebellum—hypothyroidism	0.00261	0.0137	CbGeAlD
Triamcinolone—Body temperature increased—Liotrix—hypothyroidism	0.0026	0.00324	CcSEcCtD
Triamcinolone—CYP3A4—blood—hypothyroidism	0.00258	0.0136	CbGeAlD
Triamcinolone—Hypersensitivity—Liotrix—hypothyroidism	0.00243	0.00302	CcSEcCtD
Triamcinolone—Asthenia—Liotrix—hypothyroidism	0.00236	0.00294	CcSEcCtD
Triamcinolone—Pruritus—Liotrix—hypothyroidism	0.00233	0.0029	CcSEcCtD
Triamcinolone—PTGS2—liver—hypothyroidism	0.00231	0.0121	CbGeAlD
Triamcinolone—PTGS2—cerebellum—hypothyroidism	0.00226	0.0118	CbGeAlD
Triamcinolone—Dizziness—Liotrix—hypothyroidism	0.00218	0.00271	CcSEcCtD
Triamcinolone—Vomiting—Liotrix—hypothyroidism	0.00209	0.00261	CcSEcCtD
Triamcinolone—Rash—Liotrix—hypothyroidism	0.00208	0.00259	CcSEcCtD
Triamcinolone—Dermatitis—Liotrix—hypothyroidism	0.00208	0.00259	CcSEcCtD
Triamcinolone—Headache—Liotrix—hypothyroidism	0.00206	0.00257	CcSEcCtD
Triamcinolone—Hydrocortisone—SHBG—hypothyroidism	0.00204	0.378	CrCbGaD
Triamcinolone—CYP3A4—liver—hypothyroidism	0.00202	0.0106	CbGeAlD
Triamcinolone—Nausea—Liotrix—hypothyroidism	0.00196	0.00244	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.000114	0.105	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.000103	0.0946	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	8.13e-05	0.0748	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—THRB—hypothyroidism	6.63e-05	0.061	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	6.18e-05	0.0568	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	5.24e-05	0.0482	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	4.36e-05	0.0401	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	4e-05	0.0368	CbGpPWpGaD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	3.54e-05	0.0325	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	3.33e-05	0.0306	CbGpPWpGaD
Triamcinolone—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	2.71e-05	0.0249	CbGpPWpGaD
Triamcinolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	2.7e-05	0.0248	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	2.59e-05	0.0238	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	2.45e-05	0.0225	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	2.18e-05	0.02	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	2.17e-05	0.02	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	2.14e-05	0.0197	CbGpPWpGaD
Triamcinolone—NR3C1—Circadian Clock—AVP—hypothyroidism	1.96e-05	0.0181	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—SLC5A7—hypothyroidism	1.87e-05	0.0172	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	1.6e-05	0.0147	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	1.58e-05	0.0145	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	1.57e-05	0.0144	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	1.4e-05	0.0129	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—NEFL—hypothyroidism	1.21e-05	0.0111	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ZNF764—hypothyroidism	1.05e-05	0.00965	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	1.01e-05	0.00933	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	1e-05	0.0092	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	9.76e-06	0.00897	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	9.48e-06	0.00872	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	9.05e-06	0.00832	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	8.53e-06	0.00784	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—IYD—hypothyroidism	6.81e-06	0.00626	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—THRA—hypothyroidism	6.76e-06	0.00622	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IGF1—hypothyroidism	6.31e-06	0.0058	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ATP5O—hypothyroidism	5.79e-06	0.00532	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TPO—hypothyroidism	5.45e-06	0.005	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.05e-06	0.00464	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—TSHB—hypothyroidism	4.89e-06	0.0045	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NKX2-5—hypothyroidism	4.82e-06	0.00443	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—IYD—hypothyroidism	4.69e-06	0.00431	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—THRB—hypothyroidism	4.36e-06	0.00401	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.03e-06	0.0037	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ATP5O—hypothyroidism	3.99e-06	0.00366	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TPO—hypothyroidism	3.75e-06	0.00344	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.51e-06	0.00323	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.47e-06	0.00319	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.27e-06	0.003	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TSHB—hypothyroidism	2.52e-06	0.00232	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3C2A—hypothyroidism	2.25e-06	0.00207	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.22e-06	0.00204	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IYD—hypothyroidism	2.05e-06	0.00188	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—hypothyroidism	1.92e-06	0.00176	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC5A5—hypothyroidism	1.89e-06	0.00173	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—hypothyroidism	1.84e-06	0.00169	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.74e-06	0.0016	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.74e-06	0.0016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TSHB—hypothyroidism	1.74e-06	0.00159	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TPO—hypothyroidism	1.64e-06	0.0015	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3C2A—hypothyroidism	1.55e-06	0.00142	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.53e-06	0.0014	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRL—hypothyroidism	1.37e-06	0.00126	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A5—hypothyroidism	1.3e-06	0.00119	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—hypothyroidism	9.87e-07	0.000907	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TSHB—hypothyroidism	7.58e-07	0.000696	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—hypothyroidism	6.8e-07	0.000625	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	6.75e-07	0.000621	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.67e-07	0.000521	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—hypothyroidism	2.97e-07	0.000273	CbGpPWpGaD
